2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

Li PK 1 , Bavanandan S 2 , Mohamed R 3 , Szeto CC 1 , Wong VW 4 , Chow KM 1 Show all authors , Dan YY 5 , Huang CC 6 , Lai CL 7 , Tanwandee T 8 , Teo BW 9 , Wong GL 4 , Yeoh EK 10 , Iseki K 11 , Leung CB 1 , Park HC 12 , Kanjanabuch T 13 , Lu W 14 , Fung J 7 , Jia J 15 , Kanda E 16 , Law MC 1 , Liu H 17 , Loo CK 18 , Mak SK 18 , Lui SL 19 , Tang HL 20 , Wang AY 7 , Yu ML 21 , Cheung M 22 , Jadoul M 23

Affiliations 

  • 1 Department of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong, SAR, China
  • 2 Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
  • 3 Department of Medicine, Faculty of Medicine, University of Malaysia, Kuala Lumpur, Malaysia
  • 4 Institute of Digestive Diseases, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, SAR, China
  • 5 Division of Gastroenterology & Hepatology, National University Hospital, Singapore
  • 6 Division of Nephrology and Kidney Institute, Department of Internal Medicine, China Medical University and Hospital, Taichung, Taiwan
  • 7 Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
  • 8 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkoknoi, Bangkok, Thailand
  • 9 Division of Nephrology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  • 10 Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China
  • 11 Tomishiro Central Hospital, Okinawa, Japan
  • 12 Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 13 Center of Excellence in Kidney Metabolic Disorders, Chulalongkorn University, Bangkok, Thailand
  • 14 Department of Nephrology, First Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China
  • 15 Beijing Friendship Hospital, Capital Medical University, Beijing, China
  • 16 Department of Medical Science, Kawasaki Medical School, Okayama, Japan
  • 17 Department of Nephrology, 2nd Xiangya Hospital, Central South University, Changsha, China
  • 18 Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, China
  • 19 Department of Medicine, Tung Wah Hospital, Hong Kong, China
  • 20 Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, China
  • 21 Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
  • 22 Kidney Disease: Improving Global Outcomes (KDIGO), Brussels, Belgium
  • 23 Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium
Kidney Int Rep, 2020 Aug;5(8):1129-1138.
PMID: 32775812 DOI: 10.1016/j.ekir.2020.05.001

Abstract

In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications